Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
32
Top-10 weight
47.52%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
27
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
949.0
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | — | 25,081,037 | $25.08M | 6.24% |
| 2 | GILEAD SCIENCES INC | — | 161,829 | $22.97M | 5.71% |
| 3 | JOHNSON&JOHNSON | — | 98,323 | $22.34M | 5.56% |
| 4 | MERCK & CO | — | 201,832 | $22.26M | 5.53% |
| 5 | PFIZER INC | — | 803,654 | $21.25M | 5.28% |
| 6 | AMGEN INC | — | 60,651 | $20.74M | 5.16% |
| 7 | ABBVIE INC | — | 88,295 | $19.69M | 4.90% |
| 8 | LILLY ELI and CO | — | 18,973 | $19.68M | 4.89% |
| 9 | ABBOTT LABS | — | 159,338 | $17.42M | 4.33% |
| 10 | LIQUIDIA TECHNOLOGIES INC | — | 375,819 | $15.93M | 3.96% |
| 11 | VIATRIS INC | — | 1,061,979 | $13.90M | 3.46% |
| 12 | BRISTOL-MYERS SQUIBB CO | — | 235,011 | $12.94M | 3.22% |
| 13 | AMNEAL PHARM INC | — | 923,920 | $12.64M | 3.14% |
| 14 | PRESTIGE CONSUMER HEALTHCARE INC | — | 195,296 | $12.59M | 3.13% |
| 15 | PERRIGO CO PLC | — | 883,888 | $12.56M | 3.12% |
| 16 | SUPERNUS PHARMACEUTICALS INC | — | 248,633 | $11.97M | 2.98% |
| 17 | HARMONY BIOSCIENCES HOLDINGS INC | — | 318,252 | $11.62M | 2.89% |
| 18 | BIOGEN INC | — | 63,469 | $11.42M | 2.84% |
| 19 | ANI PHARMACEUTICALS INC | — | 138,627 | $11.35M | 2.82% |
| 20 | COLLEGIUM PHARMACEUTICAL INC | — | 246,320 | $11.31M | 2.81% |
| 21 | AMPHASTAR PHARMACEUTICALS INC | — | 420,248 | $11.13M | 2.77% |
| 22 | UNITED THERAPEUTICS CORP DEL | — | 23,557 | $11.06M | 2.75% |
| 23 | REGENERON PHARMACEUTICALS INC | — | 14,775 | $10.95M | 2.72% |
| 24 | INNOVIVA INC | — | 527,232 | $10.54M | 2.62% |
| 25 | LIGAND PHARMACEUTICALS | — | 54,255 | $10.42M | 2.59% |
| 26 | JAZZ PHARMACEUTI | — | 62,017 | $10.20M | 2.54% |
| 27 | TRAVERE THERAPEUTICS INC | — | 313,637 | $9.75M | 2.42% |
| 28 | Invesco Private Government Fund | — | 9,426,686 | $9.43M | 2.34% |
| 29 | TARSUS PHARMACEUTICALS INC | — | 136,718 | $8.82M | 2.19% |
| 30 | OCULAR THERAPEUTIX INC | — | 927,738 | $8.48M | 2.11% |
| 31 | CORCEPT THERAPEUTICS INC | — | 144,438 | $5.76M | 1.43% |
| 32 | Invesco Government & Agency Portfolio, Institutional Class | — | 139,213 | $139.21K | 0.03% |
| 33 | OMNIAB INC - 12.5 EARNOUT | — | 39,023 | $0 | 0.00% |
| 34 | OMNIAB INC - 15.00 EARNOUT | — | 39,023 | $0 | 0.00% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.